Successful outcome with anagrelide in pregnancy [1]

Annals of Hematology

Volumn 84, Issue 11, 2005, Pages 758-759

  AlKindi, Salam ^a   Dennison, David ^a   Pathare, Anil ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

ANAGRELIDE; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; BLOOD CELL COUNT; BLOOD EXAMINATION; BONE MARROW EXAMINATION; BREAST FEEDING; CASE REPORT; CONGENITAL MALFORMATION; ECHOGRAPHY; FEMALE; HUMAN; LETTER; POLYCYTHEMIA VERA; PREGNANCY DISORDER; PREGNANCY TERMINATION; PRIORITY JOURNAL; TERATOGENICITY; THROMBOCYTOSIS; THROMBOSIS; TREATMENT OUTCOME;

ADULT; BLOOD CELL COUNT; FEMALE; HUMANS; PLATELET AGGREGATION INHIBITORS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; QUINAZOLINES; SPLENOMEGALY; THROMBOCYTOSIS;

EID: 26844461103     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1059-8     Document Type: Letter

References (8)

1. Tefferi A, Silverstein MN, Petitt RM, Mesa RA, Solberg LA Jr (1997) Anagrelide as a new platelet-lowering agent in essential thrombocythemia: Mechanism of action, efficacy, toxicity, current indications. Semin Thromb Hemost 23:379-383 1:STN:280:ByiH3cfotlI%3D
2. Birgegard G, Bjorkholm M, Kutti J, Larfars G, Lofvenberg E, Markevarn B, Merup M, Palmblad J, Mauritzson N, Westin J, Samuelsson J (2004) Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders. Haematologica 89(5):520-527 1:CAS:528:DC%2BD2cXlsVWrurg%3D
3. Steurer M, Gastl G, Jedrzejczak WW, Pytlik R, Lin W, Schlogl E, Gisslinger H (2004) Anagrelide for thrombocytosis in myeloproliferative disorders: A prospective study to assess efficacy and adverse event profile. Cancer 101(10):2239-2246 10.1002/cncr.20646
4. Data on file (Prod Info Agrylin(TM), (1999))
5. Wright CA, Tefferi AA (2001) A single institutional experience with 43 pregnancies in essential thrombocythemia. Eur J Haematol 66:152-159 10.1034/j.1600-0609.2001.00367.x
6. Doubek M, Brychtova Y, Doubek R, Janku P, Mayer J (2004) Anagrelide therapy in pregnancy: Report of a case of essential thrombocythemia. Ann Hematol 83:726-727
7. Jurgens DJ, Moreno-Aspitia A, Tefferi A (2004) Anagrelide-associated cardiomyopathy in polycythemia vera and essential thrombocythemia. Haematologica 89(11):1394-1395 15531464
8. Green A, Campbell P, Buck G, Wheatley K, East C, Bareford D, Wilkins B, Walt JV, Reilly J, Harrison C (2004) The Medical Research Council PT1 trial in essential thrombocythemia. Blood 104(11):5A-6a. Abstract 6 10.1182/blood-2004-04-1501